Product Images Amoxicillin And Clavulanate Potassium

This is a description of a medication with the NDC number 0781-1874-31. It is a combination of Amoxicillin and Clavulanate potassium. The medicine is in the form of thirty film-coated tablets, each containing 250 mg of amoxicillin as trinydrate and 125 mg of clavulanic acid as clavulanate potassium. The tablets contain 0.63 mEq potassium. The medicine should be stored at controlled room temperature and kept out of reach of children. The prescribing information should be consulted for dosage details. The medicine is manufactured by Sandoz GmbH.*

NDC 0781-1831-20 is a package of 20 film-coated tablets manufactured by Sandoz. The tablets contain 500 mg of Amoxicillin as the trihydrate, 125 mg of Clavulanate Potassium as clavulanate, and 0.63 mEq potassium. The recommended dosage is one tablet every 12 hours. These tablets should be stored at 20° to 25°C (68° to 77°F) and dispensed in their original container. Patients are advised to keep the container closed and away from children. For more information, refer to the prescribing information.*

Amoxicillin and Clavulanate Potassium are combined in NDC 0781-1852-20 USP Tablets manufactured by Sandoz. Each tablet contains 875 mg of amoxicillin and 125 mg of clavulanic acid as clavulanate potassium, and 0.63 mEq potassium in a film-coated form. It is recommended to take one tablet every 12 hours, and it is advised to keep the medication in a closed container in a controlled room temperature. Patients should consult the prescribing information and store the medication between 20 and 25 °C. The tablets come in a container of 20 and should be kept out of reach of children.*

This is a description of a prescription medication, possibly called Amoxicillin and Clavulanic Acid Potassium, in oral suspension form. The product is packaged with a net contents of 4g Amoxicillin and 0.57g Clavulanic Acid, and an NDC number of 0781-6102-46. The medication should only be used if the inner seal is intact. Instructions for mixing the oral suspension are provided, along with dosing information every 12 hours as described in the accompanying prescribing information. There is a warning that the medication includes phenylalanine and must be kept tightly closed, shaken well before use, and refrigerated. The medication should be discarded after 10 days. The manufacturer is Sandoz GmbH for Sandoz Inc., Princeton, NJ.*

This is a prescription-only Amoxicillin and Clavulanate Potassium oral suspension used to treat bacterial infections. Each 5 mL contains 400 mg of Amoxicillin trihydrate and 57 mg of Clavulanic acid as clavulanate potassium. The powder should be stored between 20-25°C, and the suspension must be refrigerated and discarded after 10 days. The recommended dosage is to administer every 12 hours. The bottle must be shaken well before use. This medication should be used only if the inner seal is intact.*

This is a medication label for Amoxicillin and Clavulanate Potassium Tablets, a chewable drug available in a package containing 20 tablets. This medication's NDC number is 0781-1619-66 and it is produced by the pharmaceutical company SANDOZ.*

These are Amoxicillin and Clavulanate Potassium Tablets, USP in chewable form manufactured by SANDOZ. Each tablet contains 400 mg/57 mg* of the active ingredients. This pack comes with 20 chewable tablets. The NDC code for these tablets is 0781-1643-66.*